This undated image provided by AcelRx Pharmaceuticals shows the company’s medication Dsuvia.   On Friday, Nov. 2. 2018, U.S. regulators announced the approval of the fast-acting, super-potent opioid tablet as an alternative to IV painkillers used in hospitals.
This undated image provided by AcelRx Pharmaceuticals shows the company’s medication Dsuvia. On Friday, Nov. 2. 2018, U.S. regulators announced the approval of the fast-acting, super-potent opioid tablet as an alternative to IV painkillers used in hospitals. AcelRx Pharmaceuticals via AP Craig Sherod Photography
This undated image provided by AcelRx Pharmaceuticals shows the company’s medication Dsuvia. On Friday, Nov. 2. 2018, U.S. regulators announced the approval of the fast-acting, super-potent opioid tablet as an alternative to IV painkillers used in hospitals. AcelRx Pharmaceuticals via AP Craig Sherod Photography

FDA OKs powerful opioid pill as alternative to IV painkiller

November 02, 2018 02:29 PM